Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,454 | 4,719 | 3,383 | 3,458 | 1,264 |
| Marketable Securities | 2 | 9 | 4,559 | 6,158 | 11,153 |
| TOTAL | $7,624 | $5,828 | $9,064 | $10,909 | $13,379 |
| Non-Current Assets | |||||
| PPE Net | 5 | 32 | 33 | 36 | 40 |
| Other Non-Current Assets | 91 | 62 | 72 | 87 | 70 |
| TOTAL | $96 | $94 | $105 | $123 | $110 |
| Total Assets | $7,720 | $5,922 | $9,169 | $11,032 | $13,489 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,658 | 1,315 | 1,393 | 1,406 | 2,066 |
| TOTAL | $2,120 | $1,987 | $2,210 | $2,233 | $2,891 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 405 | 636 | 783 | 783 | 783 |
| Other Non-Current Liabilities | 33 | 21 | 17 | 22 | 6 |
| TOTAL | $1,416 | $1,456 | $1,724 | $1,925 | $2,105 |
| Total Liabilities | $3,536 | $3,443 | $3,934 | $4,158 | $4,996 |
| Shareholders' Equity | |||||
| Retained earnings | -171,237 | -162,438 | -156,829 | -155,067 | -153,397 |
| Other shareholders' equity | 1,127 | 1,127 | 1,127 | 1,127 | 1,127 |
| TOTAL | $4,184 | $2,479 | $5,235 | $6,874 | $8,493 |
| Total Liabilities And Equity | $7,720 | $5,922 | $9,169 | $11,032 | $13,489 |